Ameriprise’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26M Buy
251,040
+89,609
+56% +$10.2M 0.01% 1243
2025
Q4
$16.3M Buy
161,431
+11,450
+8% +$1.24M ﹤0.01% 1565
2025
Q3
$18.5M Buy
149,981
+20,271
+16% +$2.52M ﹤0.01% 1455
2025
Q2
$15.6M Buy
129,710
+5,898
+5% +$787K ﹤0.01% 1497
2025
Q1
$18.2M Sell
123,812
-121,874
-50% -$18.6M ﹤0.01% 1370
2024
Q4
$39.9M Buy
245,686
+31,624
+15% +$5.17M 0.01% 950
2024
Q3
$34.9M Buy
214,062
+43,755
+26% +$6.48M 0.01% 1028
2024
Q2
$23.2M Sell
170,307
-98,102
-37% -$13.6M 0.01% 1187
2024
Q1
$41.1M Buy
268,409
+115,583
+76% +$17.3M 0.01% 900
2023
Q4
$21.8M Sell
152,826
-20,971
-12% -$2.8M 0.01% 1221
2023
Q3
$22.8M Buy
173,797
+18,352
+12% +$2.79M 0.01% 1137
2023
Q2
$24.9M Buy
155,445
+191
+0.1% +$30.8K 0.01% 1129
2023
Q1
$24.6M Buy
155,254
+20,167
+15% +$3.02M 0.01% 1131
2022
Q4
$19M Buy
135,087
+12,704
+10% +$1.8M 0.01% 1261
2022
Q3
$15.8M Sell
122,383
-7,777
-6% -$1.12M 0.01% 1328
2022
Q2
$18.3M Sell
130,160
-9,691
-7% -$1.38M 0.01% 1270
2022
Q1
$19.2M Sell
139,851
-36,789
-21% -$5.64M 0.01% 1379
2021
Q4
$30.4M Sell
176,640
-12,914
-7% -$2.15M 0.01% 1109
2021
Q3
$31.7M Sell
189,554
-11,566
-6% -$1.99M 0.01% 968
2021
Q2
$36.2M Buy
201,120
+16,251
+9% +$2.97M 0.01% 951
2021
Q1
$36.2M Sell
184,869
-64,893
-26% -$12.5M 0.01% 927
2020
Q4
$50.5M Sell
249,762
-59,971
-19% -$12.4M 0.02% 730
2020
Q3
$65.1M Buy
309,733
+42,158
+16% +$9.39M 0.03% 554
2020
Q2
$58.7M Sell
267,575
-7,582
-3% -$1.51M 0.03% 560
2020
Q1
$47.6M Buy
275,157
+27,525
+11% +$4.55M 0.03% 567
2019
Q4
$38.1M Sell
247,632
-25,089
-9% -$3.75M 0.02% 821
2019
Q3
$41.6M Sell
272,721
-655,832
-71% -$104M 0.02% 751
2019
Q2
$145M Sell
928,553
-112,002
-11% -$17.1M 0.06% 305
2019
Q1
$167M Sell
1,040,555
-47,783
-4% -$7.41M 0.08% 265
2018
Q4
$170M Sell
1,088,338
-266,096
-20% -$41.5M 0.08% 251
2018
Q3
$243M Sell
1,354,434
-91,605
-6% -$13M 0.09% 248
2018
Q2
$196M Buy
1,446,039
+77,335
+6% +$9.55M 0.09% 242
2018
Q1
$182M Buy
1,368,704
+26,728
+2% +$3.59M 0.08% 248
2017
Q4
$201M Buy
1,341,976
+43,444
+3% +$5.91M 0.09% 235
2017
Q3
$170M Sell
1,298,532
-42,740
-3% -$5.74M 0.08% 261
2017
Q2
$178M Buy
1,341,272
+265,200
+25% +$35.8M 0.09% 238
2017
Q1
$147M Buy
1,076,072
+25,110
+2% +$3.25M 0.08% 270
2016
Q4
$126M Buy
1,050,962
+202,631
+24% +$23.9M 0.07% 292
2016
Q3
$106M Buy
848,331
+117,912
+16% +$15.4M 0.06% 329
2016
Q2
$101M Buy
730,419
+128,022
+21% +$16.6M 0.06% 300
2016
Q1
$75.5M Buy
602,397
+80,278
+15% +$10.2M 0.05% 377
2015
Q4
$66.4M Buy
522,119
+418,551
+404% +$52M 0.04% 402
2015
Q3
$12M Buy
103,568
+21,177
+26% +$2.38M 0.01% 1312
2015
Q2
$8.57M Sell
82,391
-1,602
-2% -$173K ﹤0.01% 1732
2015
Q1
$9.27M Buy
83,993
+12,689
+18% +$1.38M 0.01% 1616
2014
Q4
$7.43M Buy
71,304
+5,516
+8% +$552K ﹤0.01% 1759
2014
Q3
$6.32M Buy
65,788
+912
+1% +$82.5K ﹤0.01% 1860
2014
Q2
$5.93M Buy
64,876
+1,787
+3% +$160K ﹤0.01% 1962
2014
Q1
$5.55M Buy
63,089
+619
+1% +$54.3K ﹤0.01% 1946
2013
Q4
$5.79M Sell
62,470
-114,726
-65% -$10.3M ﹤0.01% 1910
2013
Q3
$14.5M Sell
177,196
-182,021
-51% -$15.4M 0.01% 1208
2013
Q2
$29.9M Buy
+359,217
New +$30.9M 0.02% 756

Other funds holding CLX

Ameriprise's CLX Position: Q1 2026 in Review

Ameriprise increased its Clorox (CLX) stake by 56% in Q1 2026, buying an estimated $10.2M and bringing the position to 251,040 shares worth $26M. The position accounts for 0.01% of the portfolio, ranked #1243.

Ameriprise first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $243M in Q3 2018. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Ameriprise held 251,040 shares of Clorox worth $26M as of Q1 2026.
  • Ameriprise bought 89,609 Clorox shares in Q1 2026, an estimated $10.2M.
  • Clorox made up 0.01% of Ameriprise's portfolio in Q1 2026, its #1243 holding.
  • Ameriprise first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's Clorox position peaked at $243M in Q3 2018.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.